Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178121 · ClinicalTrials.gov registry record · NA
eLearning for Suicide Prevention
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05178121: Completed NA study, sponsored by University of Washington.
NCT05178121 is a NA study that has completed, run by University of Washington. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05178121, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Project WISE (Workplace Integrated Support \& Education) includes developmental and pilot research to create an e-learning training in suicide safety planning enhanced with novel skill-building technologies that can be integrated into the routine workflow of nurses serving patients hospitalized for medical, surgical, or traumatic injury reasons. This study pilots an initial version of this eLearning training and collects data on the acceptability of the training and its components as well as engagement of nurses in the training. The evaluation will inform iterations of the training.
Primary Outcome
The System Usability Scale, a self-report measure using a Likert-type rating scale, will assess acceptability of the two technologic training components: Client Bot Emily and Lyssn Advisor. Client Bot Emily is a virtual patient/chat bot with the persona of a suicidal patient. Nurses chat with Emily and practice skills of asking open-ended questions and making reflections about statements Emily makes. Lyssn Advisor is an online platform that automatically codes transcripts of audio or video recor
Interventions
- BEHAVIORAL eLearning Training in Suicide Safety Planning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
What the finished NCT05178121 record still lists
NCT05178121 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which eLearning Training in Suicide Safety Planning is the first listed.
NCT05178121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05178121 about?
NCT05178121 is a clinical study titled "eLearning for Suicide Prevention". Project WISE (Workplace Integrated Support \& Education) includes developmental and pilot research to create an e-learning training in suicide safety planning enhanced with novel skill-building technologies that can be integrated into the routine workflow of nurses serving patients hospitalized for ...
What is the current status of trial NCT05178121?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-11-01. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT05178121?
The interventions under investigation include: eLearning Training in Suicide Safety Planning (BEHAVIORAL).
Who is sponsoring clinical trial NCT05178121?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05178121's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI